Effects of insulin-like growth factor-I and platelet-rich plasma on sciatic nerve crush injury in a rat model

J Neurosurg. 2011 Feb;114(2):522-8. doi: 10.3171/2010.9.JNS091928. Epub 2010 Oct 29.

Abstract

Object: Local administration of insulin-like growth factor-I (IGF-I) has been shown to increase the rate of axon regeneration in crush-injured and freeze-injured rat sciatic nerves. Local administration of platelet-rich plasma (PRP) has been also shown to have a measurable effect on facial nerve regeneration after transection in a rat model. The objective of the study was to compare the effects of locally administered IGF-I and PRP on the parameters of the Sciatic Function Index (SFI), sensory function (SF), axon count, and myelin thickness/axon diameter ratio (G-ratio) in a rat model of crush-injured sciatic nerves.

Methods: The right sciatic nerve of Wistar albino rats (24 animals) was crushed using a Yasargil-Phynox aneurysm clip for 45 minutes. All animals were randomly divided into 3 groups: Group 1 (control group) was treated with saline, Group 2 was treated with IGF-I, and Group 3 was treated with PRP. Injections were performed using the tissue expander's injection port with a connecting tube directed at the crush-injured site. Functional recovery was assessed with improvement in the SFI. Recovery of sensory function was using the pinch test. Histopathological examination was performed 3 months after the injury.

Results: The SFI showed an improved functional recovery in the IGF-I-treated animals (Group 2) compared with the saline-treated animals (Group 1) 30 days after the injury. In IGF-I-treated rats, sensory function returned to the baseline level significantly faster than in saline-treated and PRP-treated rats as shown in values between SF-2 and SF-7. The G-ratios were found to be significantly higher in both experimental groups than in the control group.

Conclusions: This study suggests that the application of IGF-I to the crush-injured site may expedite the functional recovery of paralyzed muscle by increasing the rate of axon regeneration.

MeSH terms

  • Animals
  • Axons / drug effects
  • Axons / pathology
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor I / therapeutic use*
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Nerve Crush
  • Nerve Regeneration / drug effects
  • Nerve Regeneration / physiology*
  • Platelet-Rich Plasma*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Recovery of Function
  • Sciatic Nerve / drug effects
  • Sciatic Nerve / injuries*
  • Sciatic Nerve / pathology
  • Sciatic Nerve / physiopathology
  • Sciatic Neuropathy / pathology
  • Sciatic Neuropathy / physiopathology
  • Sciatic Neuropathy / therapy*
  • Statistics, Nonparametric
  • Treatment Outcome

Substances

  • Insulin-Like Growth Factor I